Gene · 2195
Papers4,590
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 4,590
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genomic landscape of breast cancer in elderly patients. | NPJ Breast Cancer | 2025 | 40640183 | PubTator, text mining | PubMed |
| Association of anthropometric indices with rs9939609 FTO gene polymorphism among overweight/obese women with breast cancer: a case-control study. | Front Nutr | 2025 | 40630163 | PubTator, text mining | PubMed |
| High burden of variants of uncertain significance in early-onset colorectal cancer among indigenous African patients: a call for global research equity in cancer genetics. | Mol Biol Rep | 2025 | 40627234 | PubTator, text mining | PubMed |
| The interplay of genetics and fatty acid metabolism: exploring their impact on metabolic syndrome in Swedish men. | Nutr J | 2025 | 40598589 | PubTator, text mining | PubMed |
| Genetic and clinical distinction between aggressive NK-cell leukemia and extranodal NK/T-cell lymphoma with bone marrow involvement. | Sci Rep | 2025 | 40594571 | PubTator, text mining | PubMed |
| Rheological Characterization of Different Fat-Derived Products. | Aesthet Surg J | 2025 | 40576796 | PubTator, text mining | PubMed |
| Body Composition Changes in Latino Population: Longitudinal Associations of Fat and Muscle Mass Indices. | Obes Sci Pract | 2025 | 40575118 | PubTator, text mining | PubMed |
| Effect of immune infiltration intensity on the efficacy of neoadjuvant immunotherapy for esophageal cancer. | Front Immunol | 2025 | 40574841 | PubTator, text mining | PubMed |
| Physiological Benchmarks and Player Profiling in Elite Football: A Role-Specific Analysis Using T-Scores. | Sports (Basel) | 2025 | 40559693 | PubTator, text mining | PubMed |
| The Oncologist, 2025, Vol, XX, Issue XX Predictive role of ARID1A and B2M mutations and the antigen presentation pathway in the efficacy of definitive chemoradiotherapy for cervical cancer. | Oncologist | 2025 | 40536270 | PubTator, text mining | PubMed |
| Conformational dynamics and multimodal interaction of Paxillin with the focal adhesion targeting domain. | Sci Adv | 2025 | 40532016 | PubTator, text mining | PubMed |
| Next-Generation Sequencing-Based Molecular Profiling of Conjunctival Squamous Cell Carcinoma and Its Potential Application for Therapy. | Ophthalmol Sci | 2025 | 40529102 | PubTator, text mining | PubMed |
| Comprehensive assessment of genomic heterogeneity, coalterations, and outcomes of patients with colorectal cancer: An AACR GENIE project analysis. | Surgery | 2025 | 40517576 | PubTator, text mining | PubMed |
| Spectrum of Renal Angiomyolipoma with Radiologic-Pathologic Correlation. | Radiographics | 2025 | 40504730 | PubTator, text mining | PubMed |
| Anlotinib combined with benmelstobart as a chemo-free first-line treatment in advanced esophageal squamous cell carcinoma: an exploratory multicenter, single-arm phase II clinical trial. | Mol Cancer | 2025 | 40500695 | PubTator, text mining | PubMed |
| The tumor suppressor FAT1 controls YAP/TAZ protein degradation and tumor cell proliferation through E3 ligase MIB2. | PLoS One | 2025 | 40478800 | PubTator, text mining | PubMed |
| Androgen Deprivation Therapy-Induced Muscle Loss and Fat Gain Predict Cardiovascular Events in Prostate Cancer Patients. | J Cachexia Sarcopenia Muscle | 2025 | 40464195 | PubTator, text mining | PubMed |
| Appetitive traits from childhood to adolescence and cardiometabolic health. | Nutr Metab Cardiovasc Dis | 2025 | 40451681 | PubTator, text mining | PubMed |
| Comparison of Ramp and Step Graded Cardiopulmonary Exercise Tests for the Estimate of Substrate Oxidation Rates in Recreationally Active Individuals. | Int J Sport Nutr Exerc Metab | 2025 | 40447267 | PubTator, text mining | PubMed |
| Clinicopathological features and genetic mutation spectrum of primary anastomosing hemangioma arising from the kidney. | Front Immunol | 2025 | 40416971 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2195/papers?page=12